Massively parallel sequencing and identification of genes for primary lymphoedema: a perfect fit

Clinical Genetics

Volumn 80, Issue 2, 2011, Pages 110-116

  Ostergaard, P ^a   Simpson, Ma ^b   Jeffery, S ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

Exome; Lymphoedema; Milroy; Next Generation Sequencing (NGS); Primary lymphoedema

Indexed keywords

DNA SEQUENCE; EXOME; FAMILY HISTORY; GENE IDENTIFICATION; GENE ISOLATION; GENE LOCATION; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; GENE SILENCING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINE; GENETIC LINKAGE; GENETIC VARIABILITY; HUMAN; LYMPHEDEMA; MILROY DISEASE; MISSENSE MUTATION; NONSENSE MUTATION; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RNA SPLICING;

GENETIC LINKAGE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LYMPHEDEMA; SEQUENCE ANALYSIS, DNA;

EID: 79960255446     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2011.01706.x     Document Type: Review

References (39)

1. Lazareth I. Classification of lymphedema. Rev Med Intern 2002: 23 (Suppl. 3): 375s-378s.
2. Connell F, Brice G, Jeffery S, Keeley V, Mortimer P, Mansour S. A new classification system for primary lymphatic dysplasias based on phenotype. Clin Genet 2010: 77: 438-452.
3. Ferrell RE, Levinson KL, Esman JH et al. Hereditary lymphedema: evidence for linkage and genetic heterogeneity. Hum Mol Genet 1998: 7: 2073-2078.
4. Evans AL, Brice G, Sotirova V et al. Mapping of primary congenital lymphedema to the 5q35.3 region. Am J Hum Genet 1999: 64: 547-555.
5. Karkkainen MJ, Ferrell RE, Lawrence EC et al. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet 2000: 25: 153-159.
6. Irrthum A, Karkkainen MJ, Devriendt K, Alitalo K, Vikkula M. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet 2000: 67: 295-301.
7. Mangion J, Rahman N, Mansour S et al. A gene for Lymphedema-distichiasis maps to 16q24.3. Am J Hum Genet 1999: 65: 427-432.
8. Fang J, Dagenais SL, Erickson RP et al. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet 2000: 67: 1382-1388.
9. Erickson RP, Dagenais SL, Caulder MS et al. Clinical heterogeneity in lymphoedema-distichiasis with FOXC2 truncating mutations. J Med Genet 2001: 38: 761-766.
10. Bell R, Brice G, Child AH et al. Analysis of lymphoedema distichiasis families for FOXC2 mutations reveals small insertions and deletions throughout the gene. Hum Genet 2001: 108: 546-551.
11. Finegold DN, Kimak MA, Lawrence EC et al. Truncating mutations in FOXC2 cause multiple lymphedema syndromes. Hum Mol Genet 2001: 10: 1185-1189.
12. Brice G, Mansour S, Bell R et al. Analysis of the phenotypic abnormalities in lymphoedema distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24. J Med Genet 2002: 39: 478-483.
13. Hennekam RCM, Geerdink RA, Hamel BCJ et al. Autosomal recessive intestinal lymphangiectasia and lymphedema, with facial anomalies and mental retardation. Am J Med Genet 1989: 34: 593-600.
14. Alders M, Hogan BM, Gjini E et al. Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans. Nat Genet 2009: 41: 1272-1274.
15. Connell F, Kalidas K, Ostergaard P et al. Linkage and sequence analysis indicate that CCBE1 is mutated in recessively inherited generalised lymphatic dysplasia. Hum Genet 2010a: 127: 231-241.
16. Hogan BM, Bos FL, Bussmann J et al. ccbe1 is required for embryonic lymphangiogenesis and venous sprouting. Nat Genet 2009: 41: 396-398.
17. Irrthum A, Devriendt K, Chitayat D et al. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. Am J Hum Genet 2003: 72: 1470-1478.
18. Ferrell RE, Baty CJ, Kimak Ma et al. GJC2 missense mutations cause human lymphedema. Am J Hum Genet 2010: 86: 943-948.
19. Ostergaard P, Simpson MA, Brice G et al. Rapid identification of mutations in GJC2 in primary lymphoedema using whole exome sequencing combined with linkage analysis with delineation of the phenotype. J Med Genet 2011: 48: 251-255.
20. Connell F, Ostergaard P, Carver C et al.; Lymphoedema Consortium. Analysis of the coding regions of VEGFR3 and VEGFC in Milroy disease and other primary lymphoedemas. Hum Genet 2009: 9: 625-631.
21. The 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature 2010: 467: 1061-1073.
22. Gnirke A, Melnikov A, Maguire J et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol 2009: 27: 182-189.
23. Ng SB, Buckingham KJ, Lee C et al. Exome sequencing identifies the cause of a mendelian disorder. Nat Genet 2010: 42: 30-35.
24. Ng SB, Bigham AW, Buckingham KJ et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet 2010: 42: 790-793.
25. Walsh T, Shahin H, Elkan-Miller T et al. Whole exome sequencing and homozygosity mapping identify mutation in the cell polarity protein GPSM2 as the cause of nonsyndromic hearing loss DFNB82. Am J Hum Genet 2010: 87: 90-94.
26. Hoischen A, van Bon BW, Gilissen C et al. De novo mutations of SETBP1 cause Schinzel-Giedion syndrome. Nat Genet 2010: 42: 483-485.
27. Simpson MA, Irving MD, Asilmaz E et al. Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss. Nat Genet 2011: 43: 303-305.
28. Bilgüvar K, Oztürk AK, Louvi A et al. Whole-exome sequencing identifies recessive WDR62 mutations in severe brain malformations. Nature 2010: 467: 207-210.
29. Johnson JO, Gibbs JR, Van Maldergem L, Houlden H, Singleton AB. Exome sequencing in Brown-Vialetto-van Laere syndrome. Am J Hum Genet 2010: 87: 567-569.
30. Ng SB, Turner EH, Robertson PD et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 2009: 461: 272-276.
31. Ng SB, Nickerson DA, Bamshad MJ, Shendure J. Massively parallel sequencing and rare disease. Hum Mol Genet 2010: 19: R119-R124.
32. Vissers LE, de Ligt J, Gilissen C et al. A de novo paradigm for mental retardation. Nat Genet 2010: 42: 1109-1112.
33. Krawitz PM, Schweiger MR, Rödelsperger C et al. Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome. Nat Genet 2010: 42: 827-829.
34. Norrmen C, Tammela T, Petrova TV, Alitalo K. Biological basis of therapeutic lymphangiogenesis. Circulation 2011: 123: 1335-1351.
35. Holberg CJ, Erickson RP, Bernas MJ et al. Segregation analyses and a genome-wide linkage search confirm genetic heterogeneity and suggest oligogenic inheritance in some Milroy congenital primary lymphedema families. Am J Med Genet 2001: 98: 303-312.
36. Brice G, Child A, Evans A et al. Milroy disease and the VEGFR-3 mutation phenotype. J Med Genet 2005: 42: 98-102.
37. Mellor RH, Brice G, Stanton AW et al.; Lymphoedema Consortium. Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation 2007: 115: 1912-1920.
38. Sholto-Douglas-Vernon C, Bell R, Brice G et al. Lymphoedema distichiasis and FOXC2: unreported mutations, de novo mutation estimate, families without coding mutations. Hum Genet 2005: 117: 238-242.
39. Meige H. Dystrophie oedemateuse hereditaire. Presse Med 1898: 6: 341-343.